Stacie Bratcher is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Jun 2025: Convexity Scientific Inc. (New Haven, CT — other health care — 2025; $25M reported sold to 12 investors).
What this means One deal on file with the SEC, filed Jun 2025. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Douglas Wenners (1 shared filing), Henry Weinstein (1 shared filing), Ilaa Agarwal (1 shared filing), Kevin Rakin (1 shared filing), Richard Wilmot (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Stacie. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Stacie Bratcher and found 3 differences: Form D filed 51 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.